Browse Articles

Development of selective RAC1/KLRN inhibitors

Kubrat Neczaj-Hruzewicz et al. | Nov 04, 2024

Development of selective RAC1/KLRN inhibitors

Kalirin is a guanine nucleotide exchange factor (GEF) for the GTPase RAC1, linked to schizophrenia and Alzheimer’s Disease. It plays a crucial role in synaptic plasticity by regulating dendritic spine formation and actin cytoskeleton remodeling, which are essential for creating new synapses. Authors developed two novel compounds targeting kalirin, confirming that predictive modeling can indicate biological activity.

Read More...

Trust in the use of artificial intelligence technology for treatment planning

Srivastava et al. | Sep 18, 2024

Trust in the use of artificial intelligence technology for treatment planning

As AI becomes more integrated into healthcare, public trust in AI-developed treatment plans remains a concern, especially for emotionally charged health decisions. In a study of 81 community college students, AI-created treatment plans received lower trust ratings compared to physician-developed plans, supporting the hypothesis. The study found no significant differences in AI trust levels across demographic factors, suggesting overall skepticism toward AI-driven healthcare.

Read More...